Norway-based Coalition for Epidemic Preparedness Innovations (CEPI) is expanding its world-leading portfolio of potentia...
Vaxxas has completed a financing round which raised $23 million (A$34 million) in new funds. This investment round was l...
Norway-based CEPI, the Coalition for Epidemic Preparedness Innovations, is to put $5.7 million (AU$8.5 million) into the...
Chinese firm XtalPi is embarking on a strategic collaboration with CK Life Sciences, a member of the CK Hutchison Group....
The International Vaccine Institute (IVI) and ST Pharm have exchanged a Memorandum of Understanding (MoU) to establish a...
SK bioscience, a leading vaccine manufacturer based in the Republic of Korea and a key partner of the International Vacc...
Researchers from the Centenary Institute and the University of Sydney in Australia have developed a new nasal vaccinatio...
The International Vaccine Institute (IVI), in South Korea, has signed a memorandum of understanding (MOU) with Lemonex, ...
US-based Arcturus Therapeutics Holdings Inc. has announced a strategic collaboration with CSL Seqirus, a global vaccine ...
Singapore-based Hilleman Laboratories has announced collaberative efforts to develop a thermostable second-generati...
CanSino Biologics has announced that its recombinant COVID-19 vaccine (Adenovirus Type 5 Vector) for inhalation (Convide...
Globally, mass vaccination practices and procedures were not pleasant experiences for everyone. Different age groups and...
South Korea's SK bioscience has entered a strategic partnership with Singapore based Hilleman Laboratories to co-develop...
South Korea-based SK bioscience has made a new partnership agreement with Norway-based Coalition for Epidemic Preparedne...
Swiss firm LimmaTech Biologics AG has announced a license and collaboration agreement with Griffith University...
PT Etana Biotechnologies Indonesia (Etana) on 7 October, 2022, inaugurated a biopharmaceutical factory located...
Immuno Cure BioTech, a clinical stage biotechnology group based in the Hong Kong Science Park specialising in DNA vaccin...
Japanese pharmaceutical firm Takeda has announced that the Committee for Medicinal Products for Human Use...